Viridian TherapeuticsVRDN
13F holders, Q4 2025 (December 31)229holders +60
66new positions
15sold out
6famous investors
$31.12avg. 13F price*
At the end of Q4 2025, 229 institutions reported holding Viridian Therapeutics Inc. (VRDN) in their 13F filings, up 60 from Q3 2025. 66 opened new positions and 15 sold out. The largest holders were FMR LLC ($447.6M), BlackRock, Inc. ($200.2M) and Vanguard Group Inc. ($174.6M). 6 famous investors held it, including David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio), Ken Fisher (0.0% of Fisher Asset Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Viridian Therapeutics Inc.
- CUSIP
- 92790C104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 66 | $383.2M |
| Exits | 15 | $130.1M |
All 13F filers, Q3 2025 → Q4 2025: 31,179,968 shares bought and 18,081,355 shares sold, net +13,098,613 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 229 holders
| FMR LLC | 0.02% | Add +17.4% | 14,384,456 | $447.6M |
| BlackRock, Inc. | 0.00% | Add +18.5% | 6,431,923 | $200.2M |
| Vanguard Group Inc. | 0.00% | Add +29.6% | 5,612,144 | $174.6M |
| Bellevue Group AG | 2.57% | New | 4,358,527 | $135.6M |
| Fairmount Funds Management LLC | 9.27% | Add +13.1% | 3,914,458 | $121.8M |
| Venrock Adviser, LLC | 5.97% | No change | 3,882,709 | $120.8M |
| State Street Corp. | 0.00% | Add +35.7% | 3,466,560 | $107.9M |
| T. Rowe Price Associates Inc. | 0.01% | Add +42.2% | 3,439,414 | $107.0M |
| Perceptive Advisors LLC | 1.74% | Add +108.1% | 3,042,703 | $94.7M |
| Deep Track Capital, LP | 1.79% | Reduce -53.1% | 2,524,833 | $78.6M |
| Novo Holdings A/S | 5.75% | No change | 2,380,000 | $74.1M |
| Geode Capital Management, LLC | 0.00% | Add +12.8% | 1,992,174 | $62.0M |
| Baker Bros. Advisors LP | 0.36% | Add +13.0% | 1,971,678 | $61.4M |
| Wellington Management Group LLP | 0.01% | Add +75.6% | 1,971,411 | $61.4M |
| Tang Capital Management LLC | 2.76% | Reduce -36.9% | 1,792,626 | $55.8M |
| Eversept Partners, LP | 3.11% | Reduce -7.4% | 1,782,235 | $55.5M |
| Fisher Asset Management | 0.02% | Add +48.2% | 1,780,284 | $55.4M |
| Morgan Stanley | 0.00% | Add +805.6% | 1,738,225 | $54.1M |
| Avoro Capital Advisors LLC | 0.46% | New | 1,500,000 | $46.7M |
| Loomis Sayles & Co. L P | 0.06% | Reduce -4.5% | 1,481,135 | $46.1M |
| Kynam Capital Management, LP | 2.98% | Reduce -66.8% | 1,470,541 | $45.8M |
| Paradigm Biocapital Advisors LP | 1.20% | Reduce -44.7% | 1,443,102 | $44.9M |
| Alliancebernstein L.P. | 0.01% | Reduce -23.9% | 1,414,181 | $44.0M |
| Marshall Wace, LLP | 0.04% | Add +58.3% | 1,375,739 | $42.8M |
| Goldman Sachs Group Inc. | 0.01% | Add +65.3% | 1,264,047 | $39.3M |
| Jennison Associates LLC | 0.02% | New | 1,154,080 | $35.9M |
| Woodline Partners LP | 0.13% | Add +36.8% | 1,115,929 | $34.7M |
| JPMorgan Chase & Co. | 0.00% | Add +226.8% | 1,010,260 | $31.4M |
| D. E. Shaw & Co. | 0.03% | New | 1,000,717 | $31.1M |
| Bank of America Corp. | 0.00% | Add +302.9% | 990,117 | $30.8M |
| Vivo Capital, LLC | 1.98% | No change | 982,576 | $30.6M |
| Pictet Asset Management Holding SA | 0.03% | Reduce -12.1% | 922,767 | $28.7M |
| Rice Hall James & Associates, LLC | 1.52% | Add +3.9% | 884,532 | $27.5M |
| Elmind Capital, LP | 7.89% | — | 858,631 | $26.7M |
| Adage Capital Partners Gp, L.L.C. | 0.04% | Reduce -35.3% | 790,018 | $24.6M |
| Parkman Healthcare Partners LLC | 2.33% | Reduce -31.7% | 788,076 | $24.5M |
| Candriam S.C.A. | 0.12% | Reduce -8.7% | 785,098 | $24.4M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +25.8% | 748,961 | $23.3M |
| Nuveen, LLC | 0.01% | Add +358.6% | 742,337 | $23.1M |
| 5AM Venture Management, LLC | 7.21% | No change | 736,595 | $22.9M |
| First Turn Management, LLC | 2.46% | New | 690,528 | $21.5M |
| Citadel Advisors | 0.01% | Add +778.5% | 679,694 | $21.2M |
| Northern Trust Corp. | 0.00% | Add +7.7% | 668,417 | $20.8M |
| Dimensional Fund Advisors LP | 0.00% | Reduce -13.0% | 555,594 | $17.3M |
| BNP Paribas Financial Markets | 0.01% | Add +113.5% | 517,398 | $16.1M |
| Balyasny Asset Management L.P. | 0.03% | Add +148.4% | 503,868 | $15.7M |
| Deutsche Bank AG | 0.00% | Reduce -48.8% | 479,758 | $14.9M |
| Millennium Management | 0.01% | Add +237.6% | 460,125 | $14.3M |
| Rosalind Advisors, Inc. | 5.10% | Reduce -25.0% | 450,000 | $14.0M |
| Algert Global LLC | 0.21% | New | 425,039 | $13.2M |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 1.17% | No change | 423,272 | $13.2M |
| Federated Hermes, Inc. | 0.02% | Add +315322.7% | 416,358 | $13.0M |
| HighVista Strategies LLC | 2.99% | Reduce -20.6% | 372,472 | $11.6M |
| Silverarc Capital Management, LLC | 1.57% | Add +34.3% | 348,569 | $10.8M |
| Voleon Capital Management LP | 0.23% | New | 345,713 | $10.8M |
| Arrowstreet Capital, Limited Partnership | 0.01% | New | 341,258 | $10.6M |
| Panagora Asset Management Inc. | 0.04% | Reduce -14.0% | 324,746 | $10.1M |
| Raymond James Financial Inc. | 0.00% | Reduce -2.9% | 303,774 | $9.4M |
| Skandinaviska Enskilda Banken AB (publ) | 0.04% | New | 286,320 | $8.9M |
| Propel Bio Management, LLC | 7.51% | Add +213.9% | 282,531 | $8.8M |
| Jane Street Group, LLC | 0.01% | Add +689.5% | 279,607 | $8.7M |
| Davern Capital Partners, LP | 2.63% | — | 261,615 | $8.1M |
| Point72 Asset Management | 0.01% | New | 254,285 | $7.9M |
| Affinity Asset Advisors, LLC | 0.58% | No change | 250,000 | $7.8M |
| Barclays PLC | 0.00% | Add +17.3% | 244,273 | $7.6M |
| Victory Capital Management Inc. | 0.00% | Reduce -47.5% | 226,817 | $7.1M |
| Bank of New York Mellon Corp | 0.00% | Add +9.5% | 215,866 | $6.7M |
| Schonfeld Strategic Advisors LLC | 0.03% | Add +275.4% | 217,434 | $6.6M |
| Yiheng Capital Management, L.P. | 2.83% | Reduce -58.3% | 208,735 | $6.5M |
| Russell Investments Group, Ltd. | 0.01% | Add +43.3% | 193,479 | $6.0M |
| Invesco Ltd. | 0.00% | Add +127.1% | 183,468 | $5.7M |
| Principal Financial Group Inc. | 0.00% | Reduce -17.5% | 175,930 | $5.5M |
| Privium Fund Management B.V. | 0.99% | New | 173,516 | $5.4M |
| Kopp Family Office, LLC | 3.44% | Reduce -10.7% | 173,173 | $5.4M |
| Hennion & Walsh Asset Management, Inc. | 0.18% | Add +9.6% | 169,167 | $5.3M |
| Driehaus Capital Management LLC | 0.04% | Reduce -51.2% | 167,934 | $5.2M |
| UBS Group AG | 0.00% | Reduce -63.2% | 164,820 | $5.1M |
| Nomura Asset Management International Inc. | 0.01% | — | 154,739 | $4.8M |
| Stempoint Capital LP | 0.82% | New | 154,320 | $4.8M |
| Hudson Bay Capital Management LP | 0.03% | Reduce -13.6% | 151,464 | $4.7M |
| Moore Capital Management, LP | 0.10% | New | 150,000 | $4.7M |
| Wells Fargo & Company | 0.00% | Add +39.1% | 147,316 | $4.6M |
| Knott David M Jr | 2.09% | Add +24.4% | 145,000 | $4.5M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +0.3% | 139,360 | $4.3M |
| CenterBook Partners LP | 0.21% | New | 136,717 | $4.3M |
| Qube Research & Technologies Ltd | 0.01% | New | 129,532 | $4.0M |
| Swiss National Bank | 0.00% | Add +16.2% | 128,600 | $4.0M |
| Norges Bank | 0.00% | — | 122,790 | $3.8M |
| First Trust Advisors LP | 0.00% | New | 119,892 | $3.7M |
| Susquehanna International Group, LLP | 0.01% | Add +209.6% | 116,524 | $3.6M |
| TD Asset Management Inc | 0.00% | Add +44.7% | 114,002 | $3.5M |
| Manufacturers Life Insurance Company, The | 0.00% | Add +35.0% | 112,682 | $3.5M |
| Simplify Asset Management Inc. | 0.05% | Add +107.1% | 103,531 | $3.2M |
| Susquehanna Fundamental Investments, LLC | 0.11% | No change | 101,083 | $3.1M |
| Seven Grand Managers, LLC | 0.24% | New | 100,000 | $3.1M |
| Rafferty Asset Management, LLC | 0.01% | Add +46.5% | 99,750 | $3.1M |
| Rhumbline Advisers | 0.00% | Reduce -6.6% | 97,451 | $3.0M |
| Moody Aldrich Partners LLC | 0.56% | Add +29.8% | 96,187 | $3.0M |
| Merck & Co., Inc. | 1.05% | No change | 93,414 | $2.9M |
| ExodusPoint Capital Management, LP | 0.03% | Add +543.1% | 92,697 | $2.9M |
"% of holder's portfolio" is VRDN's weight in each manager's 13F, not the share of Viridian Therapeutics Inc. the manager owns.